Minimal residual disease evaluation in autologous stem cell transplantation recipients with multiple myeloma

被引：8
作者：
Gupta, Ritu [1 ]
Kumar, Lalit [2 ]
Dahiya, Meetu [1 ]
Mathur, Nitin [1 ]
Harish, P. [2 ]
Sharma, Atul [2 ]
Sharma, Om Dutt [1 ]
Shekhar, Varun [3 ]
机构：
[1] AIIMS, Lab Oncol Unit, Dr BRA IRCH, New Delhi, India
[2] AIIMS, Dept Med Oncol, Dr BRA IRCH, New Delhi, India
[3] AIIMS, Dept Anesthesia & Palliat Oncol, Dr BRA IRCH, New Delhi, India
来源：
LEUKEMIA & LYMPHOMA | 2017年 / 58卷 / 05期
关键词：
FREE LIGHT-CHAIN; IMMUNOFIXATION; CRITERIA;
D O I：
10.1080/10428194.2016.1228930
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1234 / 1237
页数：4
相关论文
共 13 条
  • [1] Prospective Study of Serum FLC and Other M-Protein Assays: When and How to Measure Response?
    Drayson, M. T.
    Morgan, G. J.
    Jackson, G. H.
    Davies, F. E.
    Owen, R. G.
    Rosss, F. M.
    Gregory, W. M.
    Navarro-Coy, N.
    Heatley, F.
    Bell, S. E.
    Szubert, A. J.
    Child, J. A.
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S56 - S56
  • [2] International uniform response criteria for multiple myeloma
    Durie, B. G. M.
    Harousseau, J-L
    Miguel, J. S.
    Blade, J.
    Barlogie, B.
    Anderson, K.
    Gertz, M.
    Dimopoulos, M.
    Westin, J.
    Sonneveld, P.
    Ludwig, H.
    Gahrton, G.
    Beksac, M.
    Crowley, J.
    Belch, A.
    Boccadaro, M.
    Turesson, I.
    Joshua, D.
    Vesole, D.
    Kyle, R.
    Alexanian, R.
    Tricot, G.
    Attal, M.
    Merlini, G.
    Powles, R.
    Richardson, P.
    Shimizu, K.
    Tosi, P.
    Morgan, G.
    Rajkumar, S. V.
    [J]. LEUKEMIA, 2006, 20 (09) : 1467 - 1473
  • [3] Abnormal serum free light chain ratio in patients with multiple myeloma in complete remission has strong association with the presence of oligoclonal bands: implications for stringent complete remission definition
    Fernandez de Larrea, Carlos
    Teresa Cibeira, Maria
    Elena, Montserrat
    Ignacio Arostegui, Juan
    Rosino, Laura
    Rovira, Montserrat
    Filella, Xavier
    Yaguee, Jordi
    Blade, Joan
    [J]. BLOOD, 2009, 114 (24) : 4954 - 4956
  • [4] Flow Cytometric Immunophenotyping and Minimal Residual Disease Analysis in Multiple Myeloma
    Gupta, Ritu
    Bhaskar, Archana
    Kumar, Lalit
    Sharma, Atul
    Jain, Paresh
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 132 (05) : 728 - 732
  • [5] Minimal residual disease in multiple myeloma: bringing the bench to the bedside
    Mailankody, Sham
    Korde, Neha
    Lesokhin, Alexander M.
    Lendvai, Nikoletta
    Hassoun, Hani
    Stetler-Stevenson, Maryalice
    Landgren, Ola
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2015, 12 (05) : 286 - U139
  • [6] Prognostic value of immunophenotyping in multiple myeloma:: A study by the PETHEMA/GEM cooperative study groups on patients uniformly treated with high-dose therapy
    Mateo, Gema
    Montalban, M. Angeles
    Vidriales, Maria-Belen
    Lahuerta, Juan J.
    Mateos, Maria V.
    Gutierrez, Norma
    Rosinol, Laura
    Montejano, Laura
    Blade, Joan
    Martinez, Rafael
    de la Rubia, Javier
    Diaz-Mediavilla, Joaquin
    Sureda, Anna
    Ribera, Joes M.
    Ojanguren, Jose M.
    de Arriba, Felipe
    Palomera, Luis
    Terol, Maria J.
    Orfao, Alberto
    Miguel, Jesus F. San
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (16) : 2737 - 2744
  • [7] Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy
    Moustafa, M. Alhaj
    Rajkumar, S. V.
    Dispenzieri, A.
    Gertz, M. A.
    Lacy, M. Q.
    Buadi, F. K.
    Hwa, Y. L.
    Dingli, D.
    Kapoor, P.
    Hayman, S. R.
    Lust, J. A.
    Kyle, R. A.
    Kumar, S. K.
    [J]. LEUKEMIA, 2015, 29 (10) : 2033 - 2038
  • [8] Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation
    Paiva, Bruno
    Vidriales, Maria-Belen
    Cervero, Jorge
    Mateo, Gema
    Perez, Jose J.
    Montalban, Maria A.
    Sureda, Anna
    Montejano, Laura
    Gutierrez, Norma C.
    de Coca, Alfonso Garcia
    Heras, Natalia de las
    Mateos, Maria V.
    Lopez-Berges, Maria C.
    Garcia-Boyero, Raimundo
    Galende, Josefina
    Hernandez, Jose
    Palomera, Luis
    Carrera, Dolores
    Martinez, Rafael
    de la Rubia, Javier
    Martin, Alejandro
    Blade, Joan
    Lahuerta, Juan J.
    Orfao, Alberto
    Miguel, Jesus F. San
    [J]. BLOOD, 2008, 112 (10) : 4017 - 4023
  • [9] New criteria for response assessment: role of minimal residual disease in multiple myeloma
    Paiva, Bruno
    van Dongen, Jacques J. M.
    Orfao, Alberto
    [J]. BLOOD, 2015, 125 (20) : 3059 - 3068
  • [10] Comparison of Immunofixation, Serum Free Light Chain, and Immunophenotyping for Response Evaluation and Prognostication in Multiple Myeloma
    Paiva, Bruno
    Martinez-Lopez, Joaquin
    Vidriales, Maria-Belen
    Mateos, Maria-Victoria
    Montalban, Maria-Angeles
    Fernandez-Redondo, Elena
    Alonso, Lourdes
    Oriol, Albert
    Teruel, Ana-Isabel
    de Paz, Raquel
    Larana, Jose-Garcia
    Bengoechea, Enrique
    Martin, Alejandro
    Diaz Mediavilla, Joaquin
    Palomera, Luis
    de Arriba, Felipe
    Blade, Joan
    Orfao, Alberto
    Lahuerta, Juan-Jose
    San Miguel, Jesus F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (12) : 1627 - 1633
12